Medication info

Curan Tablet (Ranitidine Hydrochloride)

Prescription medicationOralApproval withdrawn
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tablet
Manufacturer / importer
Ildong Pharmaceutical Co., Ltd.
Appearance
This medication is a white, round film-coated tablet.
Packaging
100 tablets (10 tablets x 10)/Alu-Alu, 300 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 198500207 · Notified 1985.11.21

This product's status changed to Approval withdrawn on 2024.07.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (such as ulcers), improvement of gastric mucosal lesions, prevention of Mendelson syndrome
Who takes it
Adults · Children
Adult dose
Administer 150 mg of ranitidine per dose orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this drug per dose orally twice daily, or 300 mg once daily at bedtime. In particular, a higher cure rate can be achieved in patients with duodenal ulcers by administering 300 mg twice daily, in the morning and at bedtime. The dosage and administration are the same when used concomitantly to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks; conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg of this drug per dose twice daily for 8 weeks, or 300 mg once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg per dose 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 150 mg of this drug per dose 3 times daily; the dose may be increased as needed. For severe cases, up to 6 g per day may be administered as directed by a physician. 4) In cases of upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions, treatment is usually initiated with an injection. Once oral administration is possible, switch to oral administration and give 150 mg of this drug per dose twice daily. 5) Preanesthetic medication (prevention of Mendelson syndrome) Administer 150 mg of this drug 2 hours before induction of anesthesia. In this case, it is also preferable to administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosions, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer 150 mg of this drug per dose once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment with a creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the plasma concentration of the drug; therefore, readjust the dosing schedule immediately after hemodialysis. Adjust the dose appropriately according to age and symptoms.
Child dose
For patients 12 years of age and older, administer 75 mg of this drug per dose orally twice daily (liquid formulation only). For patients 8 〜 18 years of age, up to 150 mg per dose (2 mg per kg of body weight) may be administered twice daily.

Ingredients

Manufacturer
Ildong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (such as ulcers), improvement of gastric mucosal lesions, prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson syndrome
  • post-surgical ulcers
  • gastric and duodenal ulcers due to NSAID administration
  • gastric mucosal lesions
  • erosion
  • bleeding
  • erythema
  • edema
  • acute gastritis
View approved original text

This medication is effective for ulcers occurring in the stomach and duodenum, and symptoms of excessive gastric acid such as Zollinger-Ellison syndrome. It can also be administered to patients with gastroesophageal reflux disease or to prevent Mendelson syndrome before surgery, and is used for ulcer treatment after surgery. It is also helpful for treating gastric and duodenal ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). Additionally, it is effective in improving gastric mucosal lesions such as acute exacerbations of acute and chronic gastritis and upper gastrointestinal bleeding. As it is also used to alleviate symptoms of heartburn or acid reflux due to excessive stomach acid, it is a good medication for overall improvement in gastric health.

How to take

Adult dose

Administer 150 mg of ranitidine per dose orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this drug per dose orally twice daily, or 300 mg once daily at bedtime. In particular, a higher cure rate can be achieved in patients with duodenal ulcers by administering 300 mg twice daily, in the morning and at bedtime. The dosage and administration are the same when used concomitantly to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks; conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg of this drug per dose twice daily for 8 weeks, or 300 mg once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg per dose 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 150 mg of this drug per dose 3 times daily; the dose may be increased as needed. For severe cases, up to 6 g per day may be administered as directed by a physician. 4) In cases of upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions, treatment is usually initiated with an injection. Once oral administration is possible, switch to oral administration and give 150 mg of this drug per dose twice daily. 5) Preanesthetic medication (prevention of Mendelson syndrome) Administer 150 mg of this drug 2 hours before induction of anesthesia. In this case, it is also preferable to administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosions, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer 150 mg of this drug per dose once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment with a creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the plasma concentration of the drug; therefore, readjust the dosing schedule immediately after hemodialysis. Adjust the dose appropriately according to age and symptoms.

Child dose

For patients 12 years of age and older, administer 75 mg of this drug per dose orally twice daily (liquid formulation only). For patients 8 〜 18 years of age, up to 150 mg per dose (2 mg per kg of body weight) may be administered twice daily.

Precautions

This medication should not be used in patients who have had allergic reactions to its ingredients or a history of acute porphyria. In patients with impaired renal function, the concentration of this medication may increase, thus dose adjustment or modification of the administration interval is necessary. Patients with compromised liver function should also use this medication with caution. Patients with a history of drug allergies and the elderly should be administered cautiously, and if taken in conjunction with NSAIDs, gastrointestinal conditions should be monitored periodically. This medication can mask symptoms of gastric cancer; therefore, use it only after confirming that newly developed or changed dyspeptic symptoms in middle-aged or older patients are not due to malignancy. Patients with Helicobacter pylori-positive gastric or duodenal ulcers require eradication therapy. Rarely, severe allergic reactions such as anaphylactic shock may occur during the use of this medication; if unusual symptoms appear, discontinue use immediately and visit a hospital. If hypersensitivity reactions appear such as urticaria, rash, difficulty breathing, or hypotension, medication should be stopped. Blood tests may show a decrease in white blood cells or platelets; if symptoms such as fatigue, bleeding, or fever occur, consult a physician. If symptoms of liver dysfunction or jaundice appear, stop taking the medication immediately and consult a healthcare professional. Rarely, symptoms such as arrhythmias, vasculitis, constipation, nausea, or abdominal pain may occur, so caution is necessary. Neuropsychiatric symptoms such as dizziness, drowsiness, headache, confusion, or hallucinations may occur, particularly in patients with reduced renal function who should be especially cautious. Rarely, symptoms such as gynecomastia, erectile dysfunction, myalgia, skin rash, and alopecia may manifest. Long-term use of this medication may lead to increased bacterial growth in the stomach due to decreased gastric acid secretion, so it should be used according to the instructions of the physician. Women who are pregnant or may become pregnant, as well as breastfeeding women, should consult a physician before taking this medication. Safety in children has not been adequately established; therefore, administration to children should be done cautiously. Elderly patients may require dose adjustment due to the potential for increased drug concentrations caused by reduced renal function. This medication may interact with other drugs, so inform the physician or pharmacist of any other medications being taken. If dizziness or drowsiness occurs after taking this medication, avoid driving or operating dangerous machinery. In case of overdose, appropriate treatment such as vomiting or gastric lavage is necessary, and in some cases, blood dialysis may be performed. This medication should be kept out of reach of children, and transferring it to other containers should be avoided.

Side effects

  • Anaphylactic shock
  • urticaria
  • angioedema
  • rash
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • increased serum creatinine levels
Show 56 more
  • leukopenia
  • thrombocytopenia
  • aplastic anemia
  • hypoplastic bone marrow
  • refractory anemia
  • agranulocytosis
  • pancytopenia
  • acquired hemolytic anemia
  • eosinophilia
  • generalized weakness
  • fatigue
  • subcutaneous bleeding
  • mucosal bleeding
  • liver dysfunction
  • jaundice
  • hepatitis
  • bradycardia
  • heart block
  • tachycardia
  • vasculitis
  • constipation
  • nausea
  • vomiting
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • diarrhea
  • acute pancreatitis
  • dizziness
  • drowsiness
  • convulsions
  • headache
  • heaviness in the head
  • insomnia
  • excitation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorder
  • consciousness disturbance
  • hepatogenic muscle spasm
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container protected from light, in a cool and dry room temperature. By storing it this way, the effect of the medication can be maintained for a longer period.

Appearance and packaging

Appearance

This medication is a white, round film-coated tablet.

Package unit

100 tablets (10 tablets x 10)/Alu-Alu, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.